Elephants Revived a “Zombie” Gene that May Fend Off Cancer
Elephants Revived a “Zombie” Gene that May Fend Off Cancer
DNA damage kick-starts what was once a defunct duplicated gene, which kills off injured cells.
Elephants Revived a “Zombie” Gene that May Fend Off Cancer
Elephants Revived a “Zombie” Gene that May Fend Off Cancer

DNA damage kick-starts what was once a defunct duplicated gene, which kills off injured cells.

DNA damage kick-starts what was once a defunct duplicated gene, which kills off injured cells.

cancer, epigenetics, science publishing
Jury Finds Monsanto’s Roundup Responsible for Man’s Cancer
Jury Finds Monsanto’s Roundup Responsible for Man’s Cancer
Sukanya Charuchandra | Aug 13, 2018
A San Francisco court levels $289 Million in damages against the pesticide maker.
Studies Unable to Reproduce Results of Two Diabetes Papers
Studies Unable to Reproduce Results of Two Diabetes Papers
Anna Azvolinsky | Aug 10, 2018
The original work found that an anti-malaria drug or the neurotransmitter GABA could increase the number of insulin-producing pancreatic cells in mice.
Effort to Reproduce Cancer Studies Scales Down to 18 Papers
Effort to Reproduce Cancer Studies Scales Down to 18 Papers
Diana Kwon | Aug 1, 2018
The Reproducibility Project: Cancer Biology initially aimed to replicate the results of 50 high-impact research articles.
Opinion: Learning from Immunotherapy’s Recent Failures
Opinion: Learning from Immunotherapy’s Recent Failures
Luis Felipe Campesato | Aug 1, 2018
The promise of immunotherapy is real. We now need to figure out how to maximize the number of patients the approach benefits.
Third Retraction for Harvard Cancer Biologist
Third Retraction for Harvard Cancer Biologist
Katarina Zimmer | Jul 25, 2018
The move follows two major corrections to a 2011 Nature paper, in which researchers demonstrated that a natural compound selectively kills cancer cells.
German Scientists Frequently Publish in Predatory Journals
German Scientists Frequently Publish in Predatory Journals
Catherine Offord | Jul 19, 2018
At least 5,000 of the country’s researchers have published their work on questionable platforms, often forking over exorbitant fees, a report finds.
Cancer Geneticist Quits After Harassment Allegations
Cancer Geneticist Quits After Harassment Allegations
Kerry Grens | Jul 17, 2018
Accusations that Nazneen Rahman bullied employees at the Institute of Cancer Research in the U.K. stretch back 12 years.
CRISPR Gene Editing Deletes, Shuffles More Genes than IntendedCRISPR Gene Editing Deletes, Shuffles More Genes than Intended
CRISPR Gene Editing Deletes, Shuffles More Genes than Intended
Ashley Yeager | Jul 16, 2018
The DNA-cutting enzyme used in the technique is not as precisely targeted as scientists had thought, and investors take notice.
Traitorous Tumor Cells Kill Their Own Kind
Traitorous Tumor Cells Kill Their Own Kind
Ruth Williams | Jul 11, 2018
Researchers plan to turn cancer cells into defectors, engineering them to kill the tumors from whence they came, and have tested the approach in mice.